Barriers to gBRCA Testing in High-Risk HER2-Negative Early Breast Cancer.
Saved in:
| Title: | Barriers to gBRCA Testing in High-Risk HER2-Negative Early Breast Cancer. |
|---|---|
| Authors: | Foroughi O; Health Advances LLC, Newton, MA 02466, USA., Madraswala S; Health Advances LLC, Newton, MA 02466, USA., Hayes J; AstraZeneca, Gaithersburg, MD 20878, USA., Glover K; AstraZeneca, Gaithersburg, MD 20878, USA., Lee L; AstraZeneca, Gaithersburg, MD 20878, USA.; Merck & Co., Inc., Rahway, NJ 07065, USA., Chaki M; AstraZeneca, Gaithersburg, MD 20878, USA., Redpath S; AstraZeneca, Gaithersburg, MD 20878, USA., Yu AW; Merck & Co., Inc., Rahway, NJ 07065, USA., Chiu D; Merck & Co., Inc., Rahway, NJ 07065, USA., Amanti KG; Health Advances LLC, Newton, MA 02466, USA., Gustavsen G; Health Advances LLC, Newton, MA 02466, USA. |
| Source: | Journal of personalized medicine [J Pers Med] 2023 Aug 03; Vol. 13 (8). Date of Electronic Publication: 2023 Aug 03. |
| Publication Type: | Journal Article |
| Journal Info: | Publisher: MDPI AG Country of Publication: Switzerland NLM ID: 101602269 Publication Model: Electronic Cited Medium: Print ISSN: 2075-4426 (Print) Linking ISSN: 20754426 NLM ISO Abbreviation: J Pers Med Subsets: PubMed not MEDLINE |
| Database: | MEDLINE Ultimate |
|
Full text is not displayed to guests.
Login for full access.
|
|
Be the first to leave a comment!
